OR WAIT null SECS
December 01, 2023
How to build a loyal audience of brand evangelists.
November 30, 2023
JAMA study investigates whether consuming energy drinks was associated with adverse pregnancy outcomes and whether caffeine consumption affects fetal-growth restriction.
AbbVie acquiring all outstanding shares of ImmunoGen, Inc. for $31.26 per share, valuing the company at a total equity value of approximately $10.1 billion.
November 29, 2023
Capan discusses the industry is embracing new technologies and how these use cases may evolve in the coming year.
November 17, 2023
Heliyon study evaluates online information, labeling accuracy, and quantitative analysis of high peroxide content gels.
November 15, 2023
Dozens of companies are selling stem cell treatments and exosome therapies that have not been approved for use or authorized for emergency use by the FDA.
November 14, 2023
Novo Nordisk said it will continue providing Levemir vials and the Levemir FlexPen for diabetes control while supplies last, until the full product discontinuation at the end of 2024.
Webinar Date/Time: Wed, Dec 6, 2023 2:00 PM EST
November 13, 2023
C-Suites and their boards should remember that digital transformation is a key part of the larger focus of a profound business transformation.
November 06, 2023
Glyburide and metformin are active ingredients in several prescription-only medications indicated for the treatment of patients with type 2 diabetes.